Doctor Statistics - Canada, France, Germany, Italy, Japan, Spain, UK

  • View
    228

  • Download
    5

Embed Size (px)

Text of Doctor Statistics - Canada, France, Germany, Italy, Japan, Spain, UK

  • EphMRA Foundation Committee Report Doctor Statistics in Canada, France, Germany, Italy, Japan, Spain, UK, USA 2008

    From EphMRA

    This project fulfils a long standing need of international pharmaceutical researchers for

    better access to doctor universe statistics. There has been a high level of interest in this

    project and we hope it helps meet your needs.

    The brief was to establish Doctor numbers/populations and bring this data together in one

    report. This report will help researchers to have greater confidence in the representation

    of doctor samples.

    The sources of the data are shown and given in as much detail as possible according to

    what is available in each country. Of course standardized data is not available across all

    countries and so the best available has been included in this report.

    This project is an EphMRA funded research project and the project was awarded after a

    Request for Proposals on Doctor Statistics was sent out and the resulting proposals

    evaluated.

    The content of this report is confidential and intended for the sole use of EphMRA

    members. We accept no liability for any errors in the report, nor from any use of the

    data. Getting accurate doctor statistics can be notoriously difficult and the figures

    included here should be considered as reasonable best estimates given the variety of

    assumptions underlying the data. Any assumptions made or points of clarification have

    been outlined where appropriate in the report. This report reflects the work and views of

    the commissioned agency and not EphMRA.

  • 2

    Should you have any questions or comments about this report then please feel free to

    contact EphMRA as follows:

    Bernadette Rogers

    EphMRA General Secretary

    generalsecretary@ephmra.org

    www.ephmra.org

    Feedback is always welcomed as we use this input to further improve other funded

    projects.

  • EphMRA Foundation Committee Report Doctor Statistics in Canada, France, Germany, Italy, Japan, Spain, UK, USA 2008

    Contents

    Pg #

    1 Acknowledgements 12

    2 Report Author Biographies 13

    3 Introduction 14

    4 Objectives 15

    5 Methodology 16

    6 Sources of Information 17

    6.1 URLs Consulted 17

    6.2 Direct Consultations by e-mail, fax or telephone 20

    6.3 Summary of Relevant Facts and Strategies for Updating Data 23

    7 How to interpret the Statistical Data 33

    8 CANADA 36

    8.1 Introduction to Canada 37

    8.2 Canadas healthcare system 39

    8.3 Service delivery 43

    8.3.1 Public services 43

    8.3.2 Primary/ ambulatory care 43

    8.3.3 Secondary/inpatient, specialized ambulatory care and long term care

    44

    8.4 Healthcare financing and expenditure 45

    8.5 Resources 46

    8.6 The Canadian pharmaceuticals market 47

    8.7 Bibliography 50

    Table 1 Total Physicians by Specialty and Gender 51

    Table 2 Total Physicians by Specialty and Age 53

    Table 3 Results from the National Physician Survey 2004 Questionnaire (work Setting)

    55

  • 4

    9 FRANCE 56

    9.1 Introduction to France 57

    9.2 Frances healthcare system 59

    9.3 Healthcare insurance 60

    9.4 Service delivery 62

    9.4.1 Public hospitals 63

    9.4.2 Private hospitals 63

    9.4.3 Not-for-profit hospitals 64

    9.5 Healthcare financing and expenditure 64

    9.6 Resources 65

    9.7 The French pharmaceuticals market 66

    9.8 Bibliography 70

    Table 1 Total Physicians by Specialty and Gender 71

    Table 2 Total Physicians by Specialty and Age 73

    Table 3 Total Physicians by specialty and Major Professional Activity

    75

    10 GERMANY 77

    10.1 Introduction to Germany 78

    10.2 Germanys healthcare system 80

    10.3 Healthcare insurance 81

    10.4 Service delivery 82

    10.4.1 Ambulatory care 84

    10.4.2 Hospital care 85

    10.5 Healthcare financing and expenditure 86

    10.6 Resources 87

    10.7 The German pharmaceuticals market 89

    10.8 Bibliography 93

    Table 1 Total Physicians by Specialty and Gender 94

    Table 2 Total Physicians by Specialty and Age 96

  • 5

    Table 3 Total Physicians by Specialty and Major Professional Activity

    98

    11 ITALY 100

    11.1 Introduction to Italy 101

    11.2 Italian healthcare system 103

    11.3 Healthcare insurance 104

    11.4 Service delivery 104

    11.5 Healthcare financing and expenditure 104

    11.6 Resources 106

    11.7 Italian pharmaceutical market 106

    11.8 Bibliography 110

    Table 1 Total Physicians by Specialty and Gender 111

    12 JAPAN 113

    12.1 Introduction to Japan 114

    12.2 Japans healthcare system 116

    12.3 Public healthcare insurance in Japan 116

    12.4 Hospitals remain the first port-of-call 117

    12.5 Service delivery 119

    12.6 Healthcare financing and expenditure 120

    12.7 Resources 121

    12.8 Japanese pharmaceutical market 122

    12.9 Bibliography 125

    Table 1 Total Physicians by Specialty and Gender 126

    Table 2 Total Physicians by Specialty and Age 128

  • 6

    13 SPAIN 130

    13.1 Introduction to Spain 131

    13.2 Spanish healthcare system 134

    13.3 Healthcare insurance 136

    13.4 Service delivery 136

    13.5 Healthcare financing and expenditure 137

    13.6 Resources 139

    13.7 Spanish pharmaceutical market 140

    13.8 Bibliography 143

    Table 1 Total Physicians by Specialty and Gender 144

    Table 2 Total Physicians by Specialty and Age 146

    Table 3a Total Physicians by Gender and Major Professional Activity, 1999

    148

    Table 3b Total Physicians by Age and Major Professional Activity, 1999

    148

    14 UK 149

    14.1 Introduction to the UK 150

    14.2 The UK healthcare system 151

    14.3 Healthcare insurance 153

    14.4 Service delivery 154

    14.5 Healthcare financing and expenditure 154

    14.6 Resources 156

    14.7 The UK pharmaceutical market 156

    14.8 Bibliography 159

    England 160

    Table 1 Total Physicians by Specialty and Gender 161

    Table 2 Total Physicians by Specialty and Age 164

    Table 3 Medical Staff by specialty and Grade 167

  • 7

    Northern Ireland 171

    Table 1 Total Physicians by Specialty and Gender 172

    Table 2 Total Physicians by Specialty and Age 173

    Table 3 Medical Staff by Specialty and Grade 174

    Scotland 176

    Table 1 Total Physicians by Specialty and Gender 177

    Table 2 Total Physicians by Specialty and Age 180

    Table 3 Medical Staff by Specialty and Grade 183

    Wales 189

    Table 1 Total Physicians by Specialty and Gender 190

    Table 2 Total Physicians by Specialty and Age 193

    Table 3 Medical Staff by Specialty and Grade 196

    UK (Consolidated Data) 199

    Table 1 Total Physicians by Specialty and Gender 200

    Table 2 Total Physicians by Specialty and Age 202

    Table 3 Medical Staff by Specialty and Grade 204

    15 USA 206

    15.1 Introduction to the United States of America 207

    15.2 The US healthcare system 208

    15.3 Healthcare insurance 209

    15.4 Service delivery 211

    15.5 Healthcare financing and expenditure 213

    15.6 Resources 215

    15.7 The US pharmaceutical market 216

    15.8 Bibliography 220

    Table 1 Total Physicians by Specialty and Gender 221

  • 8

    Table 2 Total Physicians by Specialty and Age 223

    Table 3 Total Physicians by Specialty and Professional Activity 225

    Table 4 Total Physicians by Specialty, Age & Gender 234

    Table 5 D.O.s by Specialty & Age 236

    Table 6 Number of Osteopathic Physicians 238

    Table 7 Active D.O.s by gender 238

    Table 8 Active D.O.s by age category 238

    Table 9 Active (in patient care) D.O.s by self-identified specialty

    category

    239

    Table 10 Physicians by Age & Location 240

    Table 11 Total Physicians by professional activity and Location 242

    List of Figures

    1 CANADA

    Figure 1: Geopolitical map of Canada 38

    Figure 2: Healthcare provision in Canada 43

    2 FRANCE

    Figure 3: A geographical map of France 58

    Figure 4: The French healthcare system 60

    3 GERMANY

    Figure 5: Map of Germany showing states and key cities 79

    Figure 6: Structure of the German healthcare system 80

    Figure 7: German healthcare insurance coverage by type, 2003 82

    Figure 8: A number of governmental bodies, physician and pharmacist associations, and industry associations impact healthcare provision in Germany

    86

    4 ITALY

    Figure 9: Map of Italy showing key cities and regiones 102

    Figure 10: Organizational structure of the Italian healthcare system 103

    5 JAPAN

    Figure 11: Geographical map of Japan with location and names of prefectures

    115

    Figure 12: Stakeholders impacting healthcare provision in Japan 119

  • 9

    6 SPAIN

    Figure 13: Map of Spain 132

    Figure 14: Demographic distribution of Spains population, 2005 133

    Figure 15: The Spanish healthcare system 135

    Figure 16: Allocation of pharmaceutical R&D funds, 2000 141

    7 UK

    Figure 17: Map of the UK 150

    Figure 18: Structure of the UK health service 153

    8 USA

    Figure 19: USA political map 207

    Figure 20: Healthcare structure